- Home
- IMRN vs USEA Comparison
IMRN vs USEA Comparison
Compare IMRN & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- USEA
- Stock Information
- Founded
- IMRN 1994
- USEA 2004
- Country
- IMRN Australia
- USEA Greece
- Employees
- IMRN N/A
- USEA N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- USEA Marine Transportation
- Sector
- IMRN Health Care
- USEA Consumer Discretionary
- Exchange
- IMRN Nasdaq
- USEA Nasdaq
- Market Cap
- IMRN 15.0M
- USEA 17.2M
- IPO Year
- IMRN N/A
- USEA N/A
- Fundamental
- Price
- IMRN $2.11
- USEA $1.84
- Analyst Decision
- IMRN Strong Buy
- USEA Strong Buy
- Analyst Count
- IMRN 1
- USEA 1
- Target Price
- IMRN $5.00
- USEA $6.00
- AVG Volume (30 Days)
- IMRN 6.2K
- USEA 74.9K
- Earning Date
- IMRN 12-31-2024
- USEA 02-18-2025
- Dividend Yield
- IMRN N/A
- USEA 16.30%
- EPS Growth
- IMRN N/A
- USEA N/A
- EPS
- IMRN N/A
- USEA N/A
- Revenue
- IMRN $3,271,194.00
- USEA $46,160,000.00
- Revenue This Year
- IMRN N/A
- USEA $27.55
- Revenue Next Year
- IMRN N/A
- USEA $5.76
- P/E Ratio
- IMRN N/A
- USEA N/A
- Revenue Growth
- IMRN 171.67
- USEA 11.18
- 52 Week Low
- IMRN $1.59
- USEA $1.72
- 52 Week High
- IMRN $5.96
- USEA $3.00
- Technical
- Relative Strength Index (RSI)
- IMRN 52.87
- USEA 32.15
- Support Level
- IMRN $2.05
- USEA $1.72
- Resistance Level
- IMRN $2.23
- USEA $1.99
- Average True Range (ATR)
- IMRN 0.16
- USEA 0.09
- MACD
- IMRN 0.02
- USEA 0.00
- Stochastic Oscillator
- IMRN 47.06
- USEA 36.25
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.